Dual TRBC1/TRBC2 transcript expression appears to be more common in T-cell lymphomas (4/13 or 30.8% in our series) than kappa and lambda light chain co-expression in B-cell or plasma cell neoplasms [34,35,36]. The gene discussed is TRBC2; the disease is plasma cell neoplasm.